Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6610 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-04-17 (bostonrealestatetimes.com)
Top Development & Construction Projects: Kendall Common – MIT's Volpe Redevelopment & Biogen's New Global HQ - Boston Real Estate Times
Project Overview Kendall Common is a transformative mixed-use development situated on the 14-acre site of the former Volpe National Transportation Systems Center in Cambridge's Kendall Square. MITIMCo acquired the property […]
Read more
2025-03-24 (costar.com)
News | Blackstone's BioMed adds biotech hub in Boston area with added demand
Deal includes build-to-suit global headquarters for Biogen
Read more
2023-08-05 (pharmiweb.com)
FDA Approves ZURZUVAETM (zuranolone), the First and Only Oral Treatment Approved for Women with Postp
Postpartum depression (PPD) approval based on results from two Phase 3 clinical trials; in the SKYLARK Study treatment with ZURZUVAE rapidly improved symptoms of PPD at Day 15 and as early as Day 3 with sustained effect to Day 45Mental health conditions are the leading cause of maternal mortality...
Read more
2003-06-23 (marketwatch.com)
Biogen, Idec each up $1 in pre-open on deal
Shares of biotech stock Biogen undefined and Idec Pharmaceuticals undefined each rose around $1 in pre-open trading on Instinet after the two companies...
Read more